GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » DeferredTaxAndRevenue

NKGen Biotech (NKGen Biotech) DeferredTaxAndRevenue : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

NKGen Biotech's current deferred tax and revenue for the quarter that ended in Mar. 2024 was $0.00 Mil.

NKGen Biotech DeferredTaxAndRevenue Historical Data

The historical data trend for NKGen Biotech's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech DeferredTaxAndRevenue Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - -

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

NKGen Biotech DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.